Lexicon Pharmaceuticals
LXRX
#6852
Rank
S$0.88 B
Marketcap
S$1.99
Share price
-7.76%
Change (1 day)
4.91%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -S$78.88 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are S$41.46 Million. In 2025 the company made an earning of -S$64.95 Million, an increase over its 2024 earnings that were of -S$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$78.88 Million21.45%
2025 -S$64.95 Million-74.88%
2024 -S$0.26 Billion13.15%
2023 -S$0.23 Billion73.74%
2022 -S$0.14 Billion16.16%
2021 -S$0.12 Billion49.82%
2020 -S$75.57 Million-147.19%
2019 S$0.16 B-203.42%
2018 -S$0.16 Billion-15.31%
2017 -S$0.19 Billion0.2%
2016 -S$0.19 Billion2920.7%
2015 -S$6.04 Million-95.33%
2014 -S$0.13 Billion-3.61%
2013 -S$0.14 Billion-5.52%
2012 -S$0.15 Billion-4.17%
2011 -S$0.15 Billion15.5%
2010 -S$0.13 Billion8.36%
2009 -S$0.12 Billion-4.81%
2008 -S$0.13 Billion28.79%
2007 -S$96.7 Million35.71%
2006 -S$71.25 Million52.91%
2005 -S$46.6 Million-23.89%
2004 -S$61.22 Million-24.19%
2003 -S$80.75 Million-0.48%
2002 -S$81.14 Million44.12%
2001 -S$56.3 Million23.01%
2000 -S$45.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
S$10.18 B-13,024.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.44 B-1,927.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$7.33 B-9,404.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.58 Billion 631.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$78.57 M-199.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.10 B-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$29.99 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$56.32 M-171.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$21.32 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA